Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: Intra‐familial association study in an eight‐generation hyperlipidemic kindred
Authors:
- 8 April 2003
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 121A (2) , 136-140
Abstract
Defect of growth hormone receptor (GHR) is classically known to cause Laron syndrome, characterized by short stature, specific facial appearance, elevated serum growth hormone levels, and decreased insulin‐like growth factor I levels. In addition, an increased cardiovascular risk due to elevated plasma total and LDL cholesterol levels marks another feature of the disease. Growth hormone (GH) plays an important role in the regulation of lipoprotein metabolism. GH status was found to be an independent determinant of plasma total cholesterol and triglyceride levels in humans. We studied a total of 207 members of eight‐generation extended family of familial hypercholesterolemia (FH) in which affected members presented with various lipoprotein phenotypes. Intra‐familial correlation analysis of a modifier effect of a Leu526Ile substitution in GHR gene was carried out among 95 carriers for LDL receptor gene (LDLR) mutation and 112 non‐carriers. When plasma high‐density lipoprotein cholesterol (HDL‐c) levels in the LDLR‐mutation carriers were compared, a significant lowering effect of HDL‐c was observed with the Leu allele; the values were lowest among Leu/Leu homozygotes (mean ± SD = 37 ± 2 mg/dl), highest in Ile/Ile homozygotes (50 ± 4 mg/dl), and intermediate among Leu/Ile heterozygotes (41 ± 2 mg/dl) (P = 0.0021). The results indicate a significant modification of the phenotype of FH with the defective LDLR allele, by GHR Leu variation in the kindred studied.Keywords
This publication has 32 references indexed in Scilit:
- Human calcitonin receptor-like receptor for adrenomedullin: genomic structure, eight single-nucleotide polymorphisms, and haplotype analysisJournal of Human Genetics, 2001
- Co-segregation of elevated LDL with a novel mutation (D92K) of the LDL receptor in a kindred with multiple lipoprotein abnormalitiesJournal of Human Genetics, 2000
- Genetic Defects of the Growth Hormone–Insulin-like Growth Factor AxisTrends in Endocrinology & Metabolism, 2000
- The C422F Mutation of the Growth Hormone Receptor Gene Is Not Responsible for Short StatureThe Journal of Clinical Endocrinology & Metabolism, 1999
- Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiencyAtherosclerosis, 1997
- Mutations in the Gene for Lipoprotein LipaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cellsEndocrinology, 1995
- In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liverEndocrinology, 1992
- Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991